New York Life Investment Management’s PotlatchDeltic PCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,702
Closed -$362K 1184
2024
Q1
$362K Buy
7,702
+672
+10% +$30.9K ﹤0.01% 1162
2023
Q4
$345K Sell
7,030
-163
-2% -$7.46K ﹤0.01% 1127
2023
Q3
$326K Sell
7,193
-1,133
-14% -$55.9K ﹤0.01% 1068
2023
Q2
$440K Sell
8,326
-1,572
-16% -$75.6K ﹤0.01% 842
2023
Q1
$490K Sell
9,898
-861
-8% -$40.4K 0.01% 730
2022
Q4
$473K Buy
10,759
+1,215
+13% +$55K 0.01% 963
2022
Q3
$392K Buy
9,544
+700
+8% +$32.2K ﹤0.01% 962
2022
Q2
$391K Buy
+8,844
New +$456K ﹤0.01% 993

Other funds holding PCH

New York Life Investment Management's PCH Position: Q2 2024 in Review

New York Life Investment Management sold out of PotlatchDeltic (PCH) in Q2 2024, closing a stake of 7,702 shares — an estimated $362K sold.

New York Life Investment Management first reported a position in PCH in Q2 2022 and held it in 8 quarters. The position peaked at $490K in Q1 2023. 305 funds tracked by Wall St. Rank hold PCH as of Q2 2024.

  • New York Life Investment Management reported no remaining PotlatchDeltic position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 7,702 PotlatchDeltic shares in Q2 2024, an estimated $362K.
  • New York Life Investment Management first reported a position in PotlatchDeltic in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's PotlatchDeltic position peaked at $490K in Q1 2023.
  • 305 funds tracked by Wall St. Rank held PotlatchDeltic as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.